Axogen, Inc. - SIC # 3840 -

Ticker Exchange SIC # Website Latest Ticker
AXGN Nasdaq 3840 www.axogeninc.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Axogen, Inc.

Axogen (AXGN) Stock Could Be 26% Undervalued On Cash Flow Grounds - Oct 9th, 2026 12:08 pm
Flutter upgraded, AppFolio downgraded: Wall Street's top analyst calls - Oct 7th, 2026 8:00 am
Down 22.6% in 4 Weeks, Here's Why You Should You Buy the Dip in AxoGen (AXGN) - Oct 5th, 2026 6:35 am
Nasdaq Hits Fresh Ground on Chip and Software Strength as Dow, Small Caps Lag for the Week - Oct 3rd, 2026 5:00 am
Axogen Completes Acquisition of BioCircuit Technologies, Adding NerveTape™, the First FDA Cleared Device for Sutureless Peripheral Nerve Repair - Oct 1st, 2026 3:19 pm
3 Emerging Biotech Stocks With Significant Upside Potential - Sep 30th, 2026 10:45 am
Axogen Raises $200 Million to Fund BioCircuit Buyout Focused on Sutureless Nerve Repair - Sep 10th, 2026 10:31 am
2 Medical-Device Stocks Lighting Up the Options Pits - Sep 10th, 2026 8:47 am
Axogen Announces Pricing of $208.7 Million Public Offering of Common Stock - Sep 10th, 2026 4:01 am
Axogen Enters into Definitive Agreement to Acquire BioCircuit Technologies - Sep 10th, 2026 4:00 am
Axogen, Inc. to Participate in the 24th Annual Morgan Stanley Global Healthcare Conference - Sep 1st, 2026 5:00 am
Axogen (AXGN) Q2 2026 Earnings Call Transcript - Aug 7th, 2026 7:28 pm
Axogen (AXGN) Is Up 5.1% After Raising 2026 Outlook On Breast Reconstruction Surge - Has The Bull Case Changed? - Jul 30th, 2026 2:08 am
Axogen Inc (AXGN) Q2 2026 Earnings Call Highlights: Strong Revenue Growth Amidst Margin Challenges - Jul 29th, 2026 1:03 pm
AxoGen Q2 Earnings Call Highlights - Jul 29th, 2026 8:04 am
AxoGen (AXGN) Tops Q2 Earnings and Revenue Estimates - Jul 29th, 2026 6:25 am
Trace Biosciences Announces Strategic Investment from Axogen to Advance Clinical Development of its Nerve Trace Nerve-Specific Imaging Technology - Jul 29th, 2026 5:10 am
Axogen, Inc. Reports Second Quarter 2026 Financial Results - Jul 29th, 2026 5:05 am
NZS Capital Added Axogen (AXGN) as an Optionality Position - Jul 21st, 2026 8:25 am